BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9647611)

  • 1. Oxaliplatin (L-OHP): a new reality in colorectal cancer.
    Bleiberg H
    Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):1-3. PubMed ID: 9647611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
    Culy CR; Clemett D; Wiseman LR
    Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of oxaliplatin monotherapy: phase II trials in advanced colorectal cancer.
    Becouarn Y; Rougier P
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):23-31. PubMed ID: 9609105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin: a review of preclinical and clinical studies.
    Raymond E; Chaney SG; Taamma A; Cvitkovic E
    Ann Oncol; 1998 Oct; 9(10):1053-71. PubMed ID: 9834817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raltitrexed and oxaliplatin in colorectal cancer: in vitro and in vivo study of a synergistic cytostatic combination].
    Schüll B; Scheithauer W
    Acta Med Austriaca; 2002; 29(4):124-31. PubMed ID: 12424937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin in practice.
    Misset JL
    Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):4-7. PubMed ID: 9647612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer.
    Simpson D; Dunn C; Curran M; Goa KL
    Drugs; 2003; 63(19):2127-56. PubMed ID: 12962525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oxaliplatin: the first DACH platinum in clinical practice].
    Soulié P; Raymond E; Brienza S; Cvitkovic E
    Bull Cancer; 1997 Jun; 84(6):665-73. PubMed ID: 9295871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of oxaliplatin in colorectal cancer.
    O'Dwyer PJ; Johnson SW
    Semin Oncol; 2003 Jun; 30(3 Suppl 6):78-87. PubMed ID: 12802798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
    Berg D
    Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin: a review of its use in the management of metastatic colorectal cancer.
    Wiseman LR; Adkins JC; Plosker GL; Goa KL
    Drugs Aging; 1999 Jun; 14(6):459-75. PubMed ID: 10408744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective delivery of oxaliplatin to tumor tissue by nanocarrier system enhances overall therapeutic efficacy of the encapsulated oxaliplatin.
    Lila AS; Kiwada H; Ishida T
    Biol Pharm Bull; 2014; 37(2):206-11. PubMed ID: 24492717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating oxaliplatin into the management of colorectal cancer.
    Schmoll HJ; Cassidy J
    Oncologist; 2001; 6 Suppl 4():24-8. PubMed ID: 11585971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin in ovarian cancer.
    Sessa C; ten Bokkel Huinink WW; du Bois A
    Ann Oncol; 1999; 10 Suppl 1():55-7. PubMed ID: 10219454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
    Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
    Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of oxaliplatin in the therapy for advanced colorectal carcinoma].
    Nehls O; Porschen R; Gregor M; Klump B
    Z Gastroenterol; 2001 Dec; 39(12):1033-47. PubMed ID: 11753789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin: results in colorectal carcinoma.
    Carrato A; Gallego J; Díaz-Rubio E
    Crit Rev Oncol Hematol; 2002 Oct; 44(1):29-44. PubMed ID: 12398998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxaliplatin].
    Furue H
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1195-202. PubMed ID: 16121929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role and value of oxaliplatin in metastatic colorectal cancers].
    Louvet C; de Gramont A
    Rev Med Interne; 1997; 18 Suppl 4():368s-371s. PubMed ID: 9365714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
    Carnaghi C; Zucali P; Garassino I
    Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.